Amgen, Inc. (NASDAQ: AMGN) reported Q1 EPS of $1.87, $0.07 worse than the analyst estimate of $1.94. Revenue for the quarter came in at $4.52 billion versus the consensus estimate of $4.76 billion.

For earnings history and earnings-related data on Amgen, Inc. (AMGN) click here.